Bracco Imaging SpA, a world leader in diagnostic imaging and Zereau BV, a provider of unique water technology for the ...

The two companies announced the launch of a study to reduce contrast media in wastewater through sustainable urine filtration systems for hospitals and diagnostic facilities MILAN, Feb.

The TGFR, which includes Lumitrace (relmapirazin), was approved on January 17th by the U.S. Food and Drug Administration (FDA). MediBeacon continues development of future TGFR products including a ...